Imvotamab

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

Imvotamab

Official Name

English

ANTI-CD20/ANTI-CD3 BISPECIFIC IGM ANTIBODY IGM2323

Common Name

English

imvotamab [INN]

Common Name

English

Immunoglobulin M, anti-(human CD20 antigen) (human μ-chain), disulfide with human κ-chain, decamer,(574'→271),(574''''''''''→325)-bis(disulfide) with immunoglobulin anti-(human CD3 antigen ε-chain) (human single-chain Fv fragment VH-(GGGGS)3-VL) f

Common Name

English

IGM-2323

Code

English

IMVOTAMAB [USAN]

Common Name

English

IGM2323

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

907622

Created by admin on Sat Dec 16 14:38:02 GMT 2023 , Edited by admin on Sat Dec 16 14:38:02 GMT 2023

Code System Code Type Description

USAN

LM-34

Created by admin on Sat Dec 16 14:38:02 GMT 2023 , Edited by admin on Sat Dec 16 14:38:02 GMT 2023

PRIMARY

NCI_THESAURUS

C165166

Created by admin on Sat Dec 16 14:38:02 GMT 2023 , Edited by admin on Sat Dec 16 14:38:02 GMT 2023

PRIMARY

NCIT

CAS

2573121-53-4

Created by admin on Sat Dec 16 14:38:02 GMT 2023 , Edited by admin on Sat Dec 16 14:38:02 GMT 2023

PRIMARY

INN

12054

Created by admin on Sat Dec 16 14:38:02 GMT 2023 , Edited by admin on Sat Dec 16 14:38:02 GMT 2023

PRIMARY

FDA UNII

F3HG38I0T1

Created by admin on Sat Dec 16 14:38:02 GMT 2023 , Edited by admin on Sat Dec 16 14:38:02 GMT 2023

PRIMARY

ACTIVE MOIETY


					F3HG38I0T1

Imvotamab